VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6004
+0.0067 (1.13%)
Feb 27, 2026, 4:00 PM EST - Market closed
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $19.99 million as of February 27, 2026. Its market cap has decreased by -46.02% in one year.
Market Cap
19.99M
Enterprise Value
-9.02M
1-Year Change
-46.02%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $19.99M, a decrease of -91.30%. That is a compound annual growth rate of -33.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 19.99M | 3.50% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 21.82M |
| NanoViricides | 21.60M |
| Intensity Therapeutics | 19.76M |
| Cadrenal Therapeutics | 19.59M |
| Jupiter Neurosciences | 19.53M |
| Serina Therapeutics | 19.52M |
| Pasithea Therapeutics | 19.34M |
| FibroBiologics | 18.82M |